Trials / Completed
CompletedNCT06575504
Ultrasonographical of Suprarenal Gland in High Risk Neonates
Ultrasonographical Study of Suprarenal Gland in High Risk Neonates
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 105 (actual)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- All
- Age
- 1 Day – 10 Days
- Healthy volunteers
- Not accepted
Summary
Observation study The aim is to study the suprarenal blood flow among high-risk neonates and its relation to the risk factors
Detailed description
Ultrasonographical study of the suprarenal gland in high risk newborn infants Al-Zhrraa University hospital Sample size 105 Inclusion criteria: 1- High-risk newborn 2- Need NICU admission Exclusion criteria: Cases with Major congenital anomalies and NEC Primary outcome: Abnormal suprarenal blood flow Informed consent will be obtained from all parents and mothers of the newborns enrolled in the study. All cases will be subjected to - Full history taking: (prenatal -natal - postnatal). According to the routine admission sheet of NICU of Alzahraa University Hospital, Faculty of Medicine for girls, AL-Azhar University, Cairo, Egypt. Through clinical examination (APGAR score -estimation of gestational age using modified Ballard score \"Ballard, 1991\" - body weight - severity of respiratory illness using Downs score and Silverman\'s score). Laboratory investigations: * Blood gases. * Serum electrolytes and blood glucose. * CBC. CRP. * Liver and kidney functions. Radiological evaluation: in the form of Abdominal and chest x-ray. Ultrasonographical studies were done for suprarenal gland blood flow. - Statistical Analysis, Data were collected, revised, coded, and entered into the statistical package for social science (SPSS)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Ultrasonographical examination | Study size and Doppler / blood flow / of the suprarenal gland |
Timeline
- Start date
- 2023-11-15
- Primary completion
- 2024-07-15
- Completion
- 2024-08-15
- First posted
- 2024-08-28
- Last updated
- 2024-08-28
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06575504. Inclusion in this directory is not an endorsement.